Hemispherx Biopharma, Inc. (AMEX: HEB) today announced that its six-year litigation battle with the South African investment conglomerate JCI Ltd ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE